Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Predictors of relapse in the year after hospital discharge among patients with schizophrenia.

Schennach R, Obermeier M, Meyer S, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ, Riedel M.

Psychiatr Serv. 2012 Jan;63(1):87-90. doi: 10.1176/appi.ps.201100084.

PMID:
22227766
2.

Treatment adherence and insight in schizophrenia.

Bitter I, Fehér L, Tényi T, Czobor P.

Psychiatr Hung. 2015;30(1):18-26.

PMID:
25867885
4.

Quality of life and clinical predictors of rehospitalization of persons with severe mental illness.

Postrado LT, Lehman AF.

Psychiatr Serv. 1995 Nov;46(11):1161-5.

PMID:
8564506
5.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
6.

Cost of relapse in schizophrenia.

Weiden PJ, Olfson M.

Schizophr Bull. 1995;21(3):419-29.

PMID:
7481573
7.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
8.

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.

Ciudad A, San L, Bernardo M, Olivares JM, Polavieja P, Valladares A, Gilaberte I.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):245-50. doi: 10.1016/j.pnpbp.2011.10.014. Epub 2011 Oct 26.

PMID:
22056291
9.

Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.

Haas GL, Garratt LS, Sweeney JA.

J Psychiatr Res. 1998 May-Aug;32(3-4):151-9.

PMID:
9793868
10.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Review. French.

PMID:
19250998
11.

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.

Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ.

Psychiatr Q. 2012 Jun;83(2):187-207. doi: 10.1007/s11126-011-9193-z.

PMID:
22038270
12.

Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.

Weinmann S, Janssen B, Gaebel W.

J Clin Psychiatry. 2004 Aug;65(8):1099-105.

PMID:
15323596
13.

Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.

McCann TV, Clark E, Lu S.

J Adv Nurs. 2009 Mar;65(3):534-43. doi: 10.1111/j.1365-2648.2008.04906.x.

PMID:
19222651
14.

Attitude towards adherence in patients with schizophrenia at discharge.

Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.

J Psychiatr Res. 2009 Dec;43(16):1294-301. doi: 10.1016/j.jpsychires.2009.05.003. Epub 2009 Jun 7.

PMID:
19505697
15.

One year outcome in first episode schizophrenia. Predictors of relapse.

Uçok A, Polat A, Cakir S, Genç A.

Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):37-43. Epub 2005 Jul 18.

PMID:
16010602
16.

Predicting medication noncompliance after hospital discharge among patients with schizophrenia.

Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ.

Psychiatr Serv. 2000 Feb;51(2):216-22.

PMID:
10655006
17.

[Frequency of remission in schizophrenia patients at one year follow-up].

Zimmermann J, Wolter A, Hannöver W, Krischke N.

Psychiatr Prax. 2009 May;36(4):182-8. doi: 10.1055/s-0028-1090035. Epub 2008 Dec 2. German.

PMID:
19051158
18.

Posthospital course and outcome in schizophrenia.

Carone BJ, Harrow M, Westermeyer JF.

Arch Gen Psychiatry. 1991 Mar;48(3):247-53.

PMID:
1671742
19.

[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].

Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.

Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28. French.

PMID:
23541914
20.

A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.

Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM.

J Clin Psychiatry. 2006 Aug;67(8):1194-203.

PMID:
16965196

Supplemental Content

Support Center